Microbiome Therapeutics Innovation Group
Acronym: MTIG
General Information
Identification Code: 816403444920-97
Website: [object Object]
Entity Form: U.S. 501c6
Registration Category: Professional consultancies
Registration Date: 12/11/2021
Last Update: 11/1/2023
EP Accredited Number: 0
Mission & Interests
Goals: The Microbiome Therapeutics Innovation Group (MTIG) is an independent 501(c)(6) coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to address unmet medical needs, improve clinical outcomes, and reduce health care costs.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Public health
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: consultation for the revision of the general EU pharmaceutical legislation
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 1001 Pennsylvania Ave. NWSuite 1300N
Post Code: 20003
City: Washington
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: 1001 Pennsylvania Ave. NWSuite 1300N
Post Code: 20003
City: Washington
Country: UNITED STATES
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: The goal of MTIG's involvement in the E.U is to provide comment on the following consultation:
https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12963-Revision-of-the-EU-general-pharmaceuticals-legislation/public-consultation_en
Membership Information
Members10 Percent: 1
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.10000000149011612
Structure
Structure Type: Structure
Is Member Of: Microbiome Therapeutics Innovation Group
www.microbiometig.com